FDA Approves First Therapy to Reduce Pancreatitis Risk

• by Kathryn Wighton

• June 24, 2026

Oral Shigella Vaccine Hits 89% Efficacy in Challenge Trial

An investigational oral Shigella sonnei vaccine showed robust protection against shigellosis in a phase 2 controlled human infection trial.

• by Teraya Smith

• July 23, 2026

• 3 min

FDA Approves First Oral PCSK9 Inhibitor

Merck reported placebo-adjusted LDL-C reductions of 56% and 59% at week 24 in two phase 3 CORALreef trials supporting the approval.

• by Kathryn Wighton

• July 16, 2026

• 2 min

Pregnancy Health Score Tied to Later Cardiometabolic Risk

A modified cardiovascular health score during pregnancy was associated with later diagnosis of chronic hypertensive and metabolic conditions.

• by Andrea Surnit

• June 29, 2026

• 4 min